Claus S Stuerzebecher

Title: Claus S. Stuerzebecher: Innovator in Pharmaceutical Chemistry

Introduction

Claus S. Stuerzebecher is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on prostacyclin derivatives. His research has the potential to impact various therapeutic applications.

Latest Patents

Stuerzebecher holds a patent for "20-alkyl-7-oxoprostacyclin derivatives useful as pharmaceuticals." This invention concerns 20-alkyl-7-oxoprostacyclin derivatives of general Formula I, wherein R1 is the residue OR3, where R3 means hydrogen or alkyl of 1-10 carbon atoms, optionally substituted by halogen, phenyl, C1-C4-alkoxy, or C1-C4-dialkylamino. The invention also includes cycloalkyl, aryl, or a heterocyclic residue, or the residue NHR4, where R4 means hydrogen or an alkanoyl or alkanesulfonyl residue of 1-10 carbon atoms. This patent showcases his innovative approach to developing new pharmaceutical compounds.

Career Highlights

Stuerzebecher has had a distinguished career, primarily working with Schering Aktiengesellschaft, a leading pharmaceutical company. His work has focused on the development of novel compounds that can be utilized in various medical treatments. His expertise in the field has led to advancements in pharmaceutical research and development.

Collaborations

Throughout his career, Stuerzebecher has collaborated with esteemed colleagues, including Robert C. Nickolson and Helmut Vorbrueggen. These collaborations have fostered a productive environment for innovation and have contributed to the success of their joint research efforts.

Conclusion

Claus S. Stuerzebecher is a prominent figure in pharmaceutical innovation, with a patent that highlights his contributions to the field. His work continues to influence the development of new therapeutic agents, showcasing the importance of research and collaboration in advancing medical science.